United States · 
Who invested in Immunitas Therapeutics?
Immunitas Therapeutics's investors include Longwood Fund.
United States · Series B startup
Who invested in Immunitas Therapeutics
Funding summaryUpdated 26 Oct 2026
$58Mraised across 1 round since 2021, from 1 source
- Latest round
- Series B, $58MAug 2021
- Investors
- 1
The rounds
- Aug 2021
Founders and team
From the SEC filings it signed: 3 on the team.
- Amanda WagnerExecutive Officeri
- Dan MatloffExecutive Officeri
- Jeffrey GoldbergExecutive Officer, Directori
On the board, as filediChristoph WestphalJiaping GuJuergen EckhardtKai WucherpfennigLaura BrassLucio Iannone
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Immunitas Therapeutics
How much has Immunitas Therapeutics raised?
Immunitas Therapeutics has raised $58M across 1 round since 2021.
When did Immunitas Therapeutics last raise?
Immunitas Therapeutics's most recent round was a Series B of $58M in Aug 2021.
What was Immunitas Therapeutics's biggest round?
Its most recent round, $58M in Aug 2021, is also its largest on record.
Who backed Immunitas Therapeutics first?
Immunitas Therapeutics's first round on record, in Aug 2021, was backed by Longwood Fund.
What stage is Immunitas Therapeutics at?
Immunitas Therapeutics's latest named round is a Series B, in Aug 2021.
Where is Immunitas Therapeutics based?
Immunitas Therapeutics is based in the United States.
Companies like Immunitas Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.